Begins Coverage on Milestone Scientific (NYSE:MLSS) began coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a report published on Tuesday morning. The firm issued a sell rating on the stock.

Milestone Scientific Stock Performance

Shares of Milestone Scientific stock opened at $0.99 on Tuesday. The company’s fifty day simple moving average is $0.84 and its 200-day simple moving average is $0.71. The company has a market cap of $69.30 million, a price-to-earnings ratio of -9.00 and a beta of 1.38. Milestone Scientific has a 1 year low of $0.41 and a 1 year high of $1.27.

Milestone Scientific (NYSE:MLSSGet Rating) last posted its quarterly earnings results on Thursday, May 11th. The company reported ($0.02) earnings per share for the quarter. Milestone Scientific had a negative return on equity of 75.26% and a negative net margin of 93.22%. The business had revenue of $2.60 million for the quarter.

Institutional Trading of Milestone Scientific

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada acquired a new position in shares of Milestone Scientific in the 1st quarter valued at approximately $30,000. Virtu Financial LLC grew its holdings in shares of Milestone Scientific by 370.1% during the 4th quarter. Virtu Financial LLC now owns 67,265 shares of the company’s stock worth $32,000 after purchasing an additional 52,957 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of Milestone Scientific during the 1st quarter worth $35,000. Sequoia Financial Advisors LLC acquired a new stake in shares of Milestone Scientific during the 1st quarter worth $86,000. Finally, State Street Corp boosted its stake in Milestone Scientific by 15.7% in the second quarter. State Street Corp now owns 111,585 shares of the company’s stock valued at $102,000 after buying an additional 15,103 shares in the last quarter. 6.81% of the stock is owned by institutional investors.

Milestone Scientific Company Profile

(Get Rating)

Milestone Scientific, Inc is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs.

Featured Articles

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.